The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Metabolic reprogramming of human CD8+ memory T cells through loss of SIRT1
Open accessAbstract
The expansion of CD8+CD28– T cells, a population of terminally differentiated memory T cells, is one of the most consistent immunological changes in humans during aging. CD8+CD28– T cells are highly cytotoxic, and their frequency is linked to many age-related diseases. As they do not accumulate in mice, many of the molecular mechanisms regulating their fate and function remain unclear. In this paper, we find that human CD8+CD28– T cells, under resting conditions, have an enhanced capacity to use glycolysis, a function linked to decreased expression of the NAD+-dependent protein deacetylase SIRT1. Global gene expression profiling identified the transcription factor FoxO1 as a SIRT1 target involved in transcriptional reprogramming of CD8+CD28– T cells. FoxO1 is proteasomally degraded in SIRT1-deficient CD8+CD28– T cells, and inhibiting its activity in resting CD8+CD28+ T cells enhanced glycolytic capacity and granzyme B production as in CD8+CD28– T cells. These data identify the evolutionarily conserved SIRT1–FoxO1 axis as a regulator of resting CD8+ memory T cell metabolism and activity in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This cell population is characterized by decreased SIRT1 and FOXO1 levels, resulting in an enhanced glycolytic capacity and granzyme B production116.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [116]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846 · cited 5×
“Down-regulated genes included CD28 and previously reported T cell homing receptors, such as C-C chemokine receptor type 7 (CCR7) and l-selectin (CD62L), as well as long-term survival cytokine receptor IL7R (Fig.”
BackgroundInfluentialStress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., et al. (2004) · Science · doi:10.1126/science.1094637 · Cited by 3,239
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253 · cited 1×
“Enhancing the expression of the ancestral SIR2 protein in yeast and worms promotes organismal life span extension (Kaeberlein et al., 1999; Tissenbaum and Guarente, 2001).”
BackgroundPosttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204
Sirtuins as regulators of metabolism and healthspan
Houtkooper, R. H., Pirinen, E., & Auwerx, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3293 · Cited by 2,008
Joshi, N. S., Cui, W., Chandele, A., Lee, H. K., Urso, D. R., Hagman, J., Gapin, L., & Kaech, S. M. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.010 · Cited by 1,861
Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans
Tissenbaum, H. A., & Guarente, L. (2001) · Nature · doi:10.1038/35065638 · Cited by 1,603
Lin, K., Dorman, J. B., Rodan, A. R., & Kenyon, C. J. (1997) · Science · doi:10.1126/science.278.5341.1319 · Cited by 1,501
Phenotypic and functional separation of memory and effector human CD8+ T cells
Hamann, D., Baars, P. A., Rep, M. H. G., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., & Lier, R. A. W. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1407 · Cited by 1,366
Flagged first, then by citations
1 of the 78 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–121 of 121
Sirtuins in hematopoiesis and blood malignancies
Vázquez, B. N., Fernández-Duran, I., & Vaquero, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814118-2.00020-3 · Cited by 3
The Role and Research Progress of CD8+ T Cells in Sepsis
Wang, X., Huang, Q. Y., Zuo, Z., Wang, Z., Zhang, L., & Qian, Z. (2025) · Biomedicines · doi:10.3390/biomedicines13122912 · Cited by 3
Sirtuin 5 is Dispensable for CD8+ T Cell Effector and Memory Differentiation
Duan, Q., Ding, J., Li, F., Liu, X., Zhao, Y., Yu, H., Liu, Y. U., & Zhang, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.761193 · Cited by 2
Potential role of mesenchymal stem cells in T cell aging
Zhong, X., Chen, J., Bo, W., Wu, X., Li, M., Du, F., Chen, Y., Deng, S., Zhao, Y., Shen, J., et al. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02371-y · Cited by 4
Sirtuin 1 as an emerging exerkine in the aging process: unveiling its multifaceted biological roles
Leite, P. L. D. A., Maciel, L. A., Patricio, R. C. B., Pereira, G. L. C., Lamounier, A. S. D. O., Aguiar, S. D. S., Sousa, C. V., Neto, I. V. D. S., & Simões, H. G. (2026) · Biogerontology · doi:10.1007/s10522-026-10442-z · Cited by 1
Pang, N., He, J., Pei, L., Xiao, Y., Gu, Y., Zhi, C., Lai, X., Chen, M., Xiao, Q., Wu, X., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.05.026 · Cited by 2
Dwyer, L. R., DeRogatis, A. M., Clancy, S., Gouirand, V., Chien, C., Rogers, E. E., Oltman, S. P., Jelliffe‐Pawlowski, L. L., Lynch, S. V., Rutishauser, R. L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.02.631038 · Cited by 1
Yu, H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822467-0.00010-3
Faculty Opinions recommendation of Signaling networks in immunometabolism.
Kane, L. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737610223.793578145
Wang, J., Zou, L., Zhao, T., Meng-ying, X., Xin, Y., Wang, X., Qu, X., Zong, J., & Wang, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1859832/v1
Ando, M., Kondo, T., Nakagawara, K., Mise‐Omata, S., & Yoshimura, A. (2023) · Research Square · doi:10.21203/rs.3.rs-3639314/v1
Nicotinamide Adenine Dinucleotide and Immunoregulation
Mou, Y.-J., & Qin, Z.-H. (2025) · Springer eBooks · doi:10.1007/978-981-97-9877-3_18
The Role of NAD+-Dependent Signal Mechanisms in Cancer Development and Treatment
Lu, T., Qin, Z., & Wu, J. (2025) · Springer eBooks · doi:10.1007/978-981-97-9877-3_33
The anti-tumoral effects of a low protein diet and of the IRE1α signaling
Turtos, A. M. (2022) · theses.fr (ABES) · doi:10.70675/fd90a3e8ze35az42fdzbd0ez966f12ddad22
Xu, M., Zhang, Z., Zhu, M., Zhang, S., Deng, J., Du, Z., Wang, Z., Zhao, H., & Qiu, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1820993
Liew, A. Y., Li, Y., Gicobi, J. K., Hirdler, J. B., Dellacecca, E. R., & Dong, H. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.05.722814 · Cited by 1
Mechanisms and intervention strategies for thymic involution and T cell senescence
Liu, Y., QIAO1, X.-N., Zhang, H., & Hong-Bo, H. U. (2026) · Shengming kexue · doi:10.3724/cbls.2026101
Yan, Y. C., Li, Z., He, H., Wu, M., Yang, H., & Wei, F. (2026) · Virulence · doi:10.1080/21505594.2026.2712045
Yu, T., Xia, M., Wu, Y., Wu, Q., Xie, J., Gao, H., & Hu, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1913598
Sirtuin signaling as therapeutic targets of immunosenescence
Calabrò, A., Accardi, G., Aiello, A., Caruso, C., Galimberti, D., Puleo, C., Zarcone, R., & Candore, G. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2737637
Targeting senescence-mediated immune resistance for enhanced tumor immunotherapy
Chen, S., Su, J., Jin, A., Liu, C., Zhang, P., Xu, Z., Pan, J., Lai, Y., & Yu, H. (2026) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2026.26
Metadata
- Authors
- Jeng, M. Y., Hull, P. A., Fei, M., Kwon, H.-S., Tsou, C.-L., Kasler, H., Ng, C.-P., Gordon, D. E., Johnson, J., Krogan, N., Verdin, E., & Ott, M.
- Affiliations
- Gladstone Institutes (US)
- Gladstone Institutes, San Francisco, CA 1
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-11-30
- Volume
- 215
- Issue
- 1
- Pages
- 51-62
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5748845
- OpenAlex
- W2771883021
- Cited by
- 121
- References
- 78
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 3 · 2023: 15 · 2022: 17 · 2021: 20 · 2020: 17 · 2019: 16 · 2018: 6 · 2017: 1
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-sa)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (P30 AI027763, 1DP1DA038043)
- James B. Pendleton Charitable Trust (NIH S10 RR028962)
- Gladstone Institutes
- National Science Foundation (1144247)
- Evangelische Studienwerk Villigst
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Keywords
- CD8+CD28- T cells, SIRT1, FOXO1, metabolic reprogramming, glycolysis, memory T cells, aging, proteasomal degradation, granzyme B, cytotoxic T lymphocytes, NAD+-dependent deacetylase, transcriptional reprogramming
- MeSH terms
- Forkhead Box Protein O1, Cytotoxicity, Immunologic, Energy Metabolism, Gene Expression Regulation, Humans, Immunologic Memory, Biomarkers, T-Lymphocyte Subsets, CD28 Antigens, CD8-Positive T-Lymphocytes, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
